🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareIs there a ceiling effect for GLP-1-mediated weight loss? Page 4

Is there a ceiling effect for GLP-1-mediated weight loss?

Dr.ObesityMed Fri, Mar 13, 2026 at 5:24 AM 20 replies 213 viewsPage 4 of 4
hans_munich
Member
534
2,345
Jul 2024
Munich, DE
Mar 13, 2026 at 11:04 AM#16

Just wanted to say — for anyone reading this Is there a ceiling thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

11 14kevin_tulsa, Dr.PainCLE, mike_mealprep and 8 others
Reply Quote Save Share Report
pat_auckland
Member
345
1,567
Jun 2024
Auckland, NZ
Mar 13, 2026 at 11:21 AM#17

Dr.ObesityMed's experience with Is there a ceiling effect resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I titrated faster. But the overall trajectory has been remarkably similar. Down 40 lbs in 5 months.

One thing I would add that Dr.ObesityMed did not mention: the relationship with food fundamentally changed.

14 22wanda_boise, NurseAsh_DET, BenResearch_OR and 11 others
Reply Quote Save Share Report
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Mar 13, 2026 at 11:38 AM#18

Saving this for reference. Quality thread.

9 19LindaRN_retired, tommy_boulder, hyun_seoul and 6 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
MASHdoc_SA
Member
456
2,345
Aug 2024
San Antonio, TX
Mar 13, 2026 at 11:55 AM#19

As a healthcare provider, I want to add some clinical context to this discussion on Is there a ceiling effect for.

Building on what Dr.ObesityMed said — the evidence base here is well-established. The key publications to reference are from the SUSTAIN program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
Last edited: Mar 13, 2026 at 2:55 PM
5 13LabKate, kate.chem, DataDave and 2 others
Reply Quote Save Share Report
Dr.NephBHM_UK
Member
456
2,123
Jun 2024
Birmingham, UK
Mar 13, 2026 at 12:12 PM#20

Subscribing to this thread. Is there a ceiling effect is exactly what I've been researching. 🙏

48 2PeptideChemSF, A1cHero_PHX, Dr.RenalNash and 45 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
What I wish I knew before starting GLP-1 therapy14 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register